Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Assets (2019 - 2025)

Historic Return on Assets for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to 0.89%.

  • Dna X's Return on Assets fell 6200.0% to 0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89%, marking a year-over-year decrease of 6200.0%. This contributed to the annual value of 0.72% for FY2024, which is 7200.0% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Return on Assets is 0.89%, which was down 6200.0% from 0.88% recorded in Q2 2025.
  • Over the past 5 years, Dna X's Return on Assets peaked at 0.01% during Q4 2023, and registered a low of 0.97% during Q4 2021.
  • Moreover, its 5-year median value for Return on Assets was 0.66% (2021), whereas its average is 0.53%.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 8500bps in 2023, then crashed by -7800bps in 2024.
  • Quarter analysis of 5 years shows Dna X's Return on Assets stood at 0.97% in 2021, then surged by 71bps to 0.29% in 2022, then surged by 102bps to 0.01% in 2023, then crashed by -13305bps to 0.77% in 2024, then decreased by -16bps to 0.89% in 2025.
  • Its Return on Assets was 0.89% in Q3 2025, compared to 0.88% in Q2 2025 and 0.82% in Q1 2025.